Clinical trials: Uremic Toxins
Shiga-like Toxin-producing Escherichia Coli
Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)
This protocol is designed to collect safety and efficacy data on patients that have been or will be treated with eculizumab for STEC-HUS, in the context of the 2011 STEC-HUS epidemic in Germany.
- Trial name
- STEC-HUS (NCT01410916)
- Testing
- Eculizumab (Soliris®)
- Where
- 22 sites in Germany
- Volunteers
- 198 people
- Sponsor
- Alexion Pharmaceuticals, Inc.